Envestnet Asset Management’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.5M Buy
273,109
+2,564
+0.9% +$210K 0.01% 1336
2025
Q4
$21.1M Sell
270,545
-66,663
-20% -$5.41M 0.01% 1169
2025
Q3
$28.6M Sell
337,208
-8,952
-3% -$717K 0.01% 1058
2025
Q2
$27.1M Buy
346,160
+29,671
+9% +$2.19M 0.01% 1059
2025
Q1
$22.9M Buy
316,489
+16,698
+6% +$1.4M 0.01% 1107
2024
Q4
$26.6M Buy
299,791
+50,163
+20% +$4.47M 0.01% 1014
2024
Q3
$21.1M Buy
249,628
+9,646
+4% +$856K 0.01% 1147
2024
Q2
$22.2M Buy
239,982
+9,434
+4% +$954K 0.01% 1070
2024
Q1
$26M Buy
230,548
+53,258
+30% +$5.32M 0.01% 965
2023
Q4
$16.5M Buy
177,290
+13,334
+8% +$1.17M 0.01% 1146
2023
Q3
$15M Buy
163,956
+56,957
+53% +$6.12M 0.01% 1129
2023
Q2
$13M Buy
106,999
+10,898
+11% +$1.18M 0.01% 1143
2023
Q1
$9.41M Buy
96,101
+7,563
+9% +$722K ﹤0.01% 1272
2022
Q4
$7.17M Buy
88,538
+3,784
+4% +$317K ﹤0.01% 1386
2022
Q3
$6.44M Sell
84,754
-4,893
-5% -$471K ﹤0.01% 1389
2022
Q2
$9.79M Buy
89,647
+16,328
+22% +$1.73M 0.01% 1150
2022
Q1
$7.29M Buy
73,319
+12,509
+21% +$1.19M ﹤0.01% 1394
2021
Q4
$5.81M Buy
60,810
+6,600
+12% +$662K ﹤0.01% 1511
2021
Q3
$6M Buy
54,210
+8,929
+20% +$1.02M ﹤0.01% 1414
2021
Q2
$5.25M Buy
45,281
+17,404
+62% +$2M ﹤0.01% 1482
2021
Q1
$2.9M Buy
27,877
+12,246
+78% +$1.52M ﹤0.01% 1725
2020
Q4
$1.88M Sell
15,631
-1,044
-6% -$105K ﹤0.01% 1792
2020
Q3
$1.45M Sell
16,675
-13,501
-45% -$1.16M ﹤0.01% 1800
2020
Q2
$2.44M Sell
30,176
-10,692
-26% -$780K ﹤0.01% 1464
2020
Q1
$2.82M Buy
40,868
+10,151
+33% +$1.07M ﹤0.01% 1257
2019
Q4
$3.51M Buy
30,717
+1,642
+6% +$204K ﹤0.01% 1312
2019
Q3
$3.8M Buy
29,075
+1,073
+4% +$140K ﹤0.01% 1199
2019
Q2
$3.43M Buy
28,002
+3,206
+13% +$368K ﹤0.01% 1256
2019
Q1
$2.6M Buy
24,796
+1,825
+8% +$196K ﹤0.01% 1339
2018
Q4
$2.35M Buy
+22,971
New +$2.55M ﹤0.01% 1252
2018
Q3
Sell
-5,268
Closed -$505K 2563
2018
Q2
$505K Buy
5,268
+1,456
+38% +$135K ﹤0.01% 1316
2018
Q1
$315K Buy
3,812
+108
+3% +$8.37K ﹤0.01% 1389
2017
Q4
$267K Buy
3,704
+1,212
+49% +$82.7K ﹤0.01% 1724
2017
Q3
$154K Sell
2,492
-2,026
-45% -$123K ﹤0.01% 1929
2017
Q2
$274K Sell
4,518
-416
-8% -$26.6K ﹤0.01% 1756
2017
Q1
$323K Sell
4,934
-689
-12% -$48.8K ﹤0.01% 1732
2016
Q4
$395K Buy
5,623
+3,578
+175% +$228K ﹤0.01% 1616
2016
Q3
$128K Buy
2,045
+590
+41% +$36.4K ﹤0.01% 2216
2016
Q2
$88K Sell
1,455
-83
-5% -$4.55K ﹤0.01% 2496
2016
Q1
$76K Sell
1,538
-32
-2% -$1.59K ﹤0.01% 2537
2015
Q4
$84K Sell
1,570
-282
-15% -$14.1K ﹤0.01% 2450
2015
Q3
$83K Buy
+1,852
New +$92.3K ﹤0.01% 2422
2015
Q1
Sell
-87
Closed -$4K 2402
2014
Q4
$4K Hold
87
﹤0.01% 2203
2014
Q3
$3K Hold
87
﹤0.01% 2439
2014
Q2
$3K Buy
+87
New +$2.81K ﹤0.01% 2442
2014
Q1
Sell
-257
Closed -$9K 2644
2013
Q4
$9K Hold
257
﹤0.01% 1797
2013
Q3
$8K Hold
257
﹤0.01% 1794
2013
Q2
$7K Buy
+257
New +$6.8K ﹤0.01% 1798

Other funds holding USPH

Envestnet Asset Management's USPH Position: Q1 2026 in Review

Envestnet Asset Management increased its US Physical Therapy (USPH) stake by 0.95% in Q1 2026, buying an estimated $210K and bringing the position to 273,109 shares worth $20.5M. The position accounts for 0.01% of the portfolio, ranked #1336.

Envestnet Asset Management first reported a position in USPH in Q2 2013 and has held it in 48 quarters since. The position peaked at $28.6M in Q3 2025. 229 funds tracked by Wall St. Rank hold USPH as of Q1 2026.

  • Envestnet Asset Management held 273,109 shares of US Physical Therapy worth $20.5M as of Q1 2026.
  • Envestnet Asset Management bought 2,564 US Physical Therapy shares in Q1 2026, an estimated $210K.
  • US Physical Therapy made up 0.01% of Envestnet Asset Management's portfolio in Q1 2026, its #1336 holding.
  • Envestnet Asset Management first reported a position in US Physical Therapy in Q2 2013 and has held it in 48 quarters since.
  • Envestnet Asset Management's US Physical Therapy position peaked at $28.6M in Q3 2025.
  • 229 funds tracked by Wall St. Rank held US Physical Therapy as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.